Darrin Disley

R&D

In the latest episode of the podcast pharmaphorum’s website editor Catherine Longworth speaks with Dr Darrin Disley, who's the CEO of Mogrify.

News

GSK's antisense-based drug for chronic hepatitis B virus (HBV) infection, Hibsago, has been approved in the US, its second major market after Japan.

Digital

A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.